Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Nexturn Bioscience Co., Ltd. (089140)
Market Closed
11 Aug, 06:30
KRX SM
All
(1)
KR
(1)
KRX SM
Primary
₩
2,390.
00
+70
+3.0172%
₩
40.48B
Market Cap
-
P/E Ratio
400%
Div Yield
42,041
Volume
-
Eps
₩
2,320
Previous Close
Watching
Watch
Add Transaction
Day Range
2,270
2,390
Year Range
1,853
3,250
Want to track
089140
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Splits
Statistics
Historical Data
Nexturn Bioscience Co., Ltd. (089140) Statistics
Valuation metrics
Market Cap
40.48B
Enterprise value
117.13B
Trailing P/E (ttm)
-1.73
Forward P/E
-
PEG ratio
0.02
Price/Sales (ttm)
0.57
Price/Book (mrq)
0.12
Enterprise Value/Revenue
1.66
Enterprise Value/EBITDA
28.33
Overview
Shares outstanding
10.43M
Float
-
Shares short
-
% Held by insiders
-
% Held by institutions
-
Average volume (10 days)
444.81K
Average volume (90 days)
178.58K
Price summary
52-Week low
1,853
52-Week high
3,250
Beta
-
50-Day moving average
2,182.3
200-Day moving average
2,330.2
Dividends and splits
Forward annual dividend rate
400
Forward annual dividend yield
0.1473%
Trailing annual dividend rate
100
Trailing annual dividend yield
0.0368%
5-Year annual dividend yield
-
Payout ratio
-
Dividend Date
5 Jan 2021
Ex-Dividend Date
29 Dec 2020
Last split factor
1:5
Last split Date
4 May 2023
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
0.29%
Operating margin
-0.01%
Operational effectiveness
Return on assets
-0.03%
Return on equity
-0.04%
Income Statement
Revenue (ttm)
70.44B
Revenue per share (ttm)
2,894.43
Quarterly revenue growth (yoy)
0.17%
Gross profit (ttm)
20.46B
EBITDA
4.13B
Net income to common (ttm)
-9.69B
Diluted EPS (ttm)
-1,190
Quarterly earnings growth (yoy)
2.98%
Balance Sheet
Total cash (mrq)
4.57M
Total cash per share (mrq)
0.38
Total debt (mrq)
96.65B
Total Debt/Equity (mrq)
0.43
Current ratio (mrq)
0.86%
Book value per share (mrq)
16,865.31
Cash Flow
Cash flow statement
-42.95B
Levered free cash flow (LFCF)
-9.69B